Chondrosamine capsules 200mg/250mg №10×6

Name Chondrosamine caps. The main active substance Release formCapsules hard gelatin cylindrical shape with hemispherical ends, 10 capsules in a blister pack, 5 blister packs together with a leaflet in a pack. Dosage 200mg/250m Indications for use Dosage and administrationAdults and children over 18 years old are taken orally with a small amount of water, 2 capsules 3 times a day. The optimal dosage regimen is determined by the doctor. The duration of admission is 1.5-3 months. A stable therapeutic effect is achieved when taken for at least 6 months. Elderly Patients Elderly patients do not require dose adjustments. There are no dosing recommendations for patients with impaired renal and/or hepatic function, as no studies have been conducted in such patients. Children and adolescents Glucosamine-containing medicinal products are not recommended for use in children and adolescents under 18 years of age, as data on safety and efficacy are not available. Application during pregnancy and lactation Due to the fact that there are no clinical data on the efficacy and safety of the drug during pregnancy and lactation, the drug should not be used during this period. PrecautionsBefore use, you should consult your doctor to exclude the presence of joint diseases for which other methods of treatment are provided. In patients with impaired glucose tolerance, monitoring of blood glucose levels is necessary and, if necessary, it is recommended to determine the need for insulin before starting treatment and periodically during treatment. In patients with a known risk factor for cardiovascular disease, it is recommended to monitor blood lipid levels, as in some cases hypercholesterolemia has been observed in patients treated with glucosamine. Exacerbation of asthma symptoms due to glucosamine administration has been reported (symptoms disappeared shortly after glucosamine administration was discontinued). Patients with asthma should be aware of the possible worsening of symptoms. No studies have been conducted in patients with hepatic or renal insufficiency. The toxicological and pharmacological profile of the product does not imply restrictions for the above patients. However, the use of the drug in patients suffering from renal (acute renal) or hepatic (severe liver) insufficiency should be carried out under the supervision of a physician. Use the drug with caution in bronchial asthma and diabetes mellitus. When using the drug in patients with impaired glucose tolerance, medical supervision is necessary. The preparation contains lactose. It should not be taken by patients with rare hereditary problems of galactose intolerance, the Lapp lactose deficiency or glucose-galactose malabsorption. Interaction with other drugs Compatible with non-steroidal anti-inflammatory drugs, paracetamol and glucocorticosteroids. Increased prothrombotic time has been reported with coumarin anticoagulants (eg warfarin and acetocoumarol). Therefore, in patients receiving coumarin anticoagulants, it is necessary to carefully monitor the start and end of glucosamine therapy. Concurrent treatment with glucosamine may increase the absorption and serum concentration of tetracycline, but the clinical significance of this interaction is unlikely. Contraindications Increased individual sensitivity to any of the components of the drug (allergic reactions), phenylketonuria, severe renal dysfunction, children under 18 years of age. Contraindicated in pregnancy and lactation. Composition One capsule contains chondroitin sulfate – 200 mg; glucosamine hydrochloride – 250 mg. Excipients: magnesium stearate, lactose. The composition of the capsule shell: gelatin, glycerin, purified water, titanium dioxide E-171, sodium lauryl sulfate, dye: sunset yellow E – 110. Overdose To date, cases of overdose are unknown. In case of overdose, treatment should be symptomatic, aimed at restoring the water and electrolyte balance. Side effect The frequency of adverse reactions indicated below was determined using the following note: very often (≥ 1/10), often (≥ 1/100 – < 1/10), infrequently (≥ 1/1000 - < 1/100), rarely (≥ 1/10000 - < 1/1000), very rare (< 1/10000), unknown (cannot be determined from the available data). Storage conditions Store in a place protected from moisture and light at a temperature of 15 ° C to 25 ° C. Store in a place inaccessible to children. Buy Chondrosamine capsules 200mg/250mg No. 10x6 Price for Chondrosamine capsules 200mg/250mg No. 10x6